All of our products and services point to the same direction: offer a shorter path to diagnosis of genetic disorders and better quality of life to all patients and their families.
This is what the gMendel®Test and Phivea® aim for; a real-time, affordable and reliable screening service that can be made available widely at a low cost and support health professionals in making accurate medical decisions and ensure the highest security & patient data encryption.
With gMendel®Care and gMendel®Hope initiatives, we aspire to bring accurate screening and fair, equal care opportunities closer to all families facing genetic disorders. We are pioneering affordable and accurate mass screening solutions for the early diagnosis of genetic conditions in prenatal and newborn care. Our mission is to alleviate the burden on countless families while significantly reducing healthcare costs.
